Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.23.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Revenue $ 0 $ 0
Costs and Operating Expenses    
Cost of revenue, excluding depreciation 0 0
Research and development expenses, excluding depreciation 47,104 82,487
Selling, general and administrative expenses, excluding depreciation 29,849 55,621
Depreciation 4,575 2,678
Total costs and operating expenses 81,528 140,786
Loss from operations (81,528) (140,786)
Other (expense) income    
Interest (expense) (296) (29)
Gain on fair value change in contingent earnout shares liability 2,505 15,465
Gain on fair value change in warrant liability 17,342 0
Loss on extinguishment of debt (26,739) 0
Other (expense), net (2,016) (17)
Loss before income taxes (90,732) (125,367)
Provision for income taxes 0 0
Net loss and comprehensive loss (90,732) (125,367)
Net loss and comprehensive loss $ (90,732) $ (125,367)
Per Share Data:    
Net loss per share, basic (in dollars per share) $ (0.22) $ (0.54)
Net loss per share, diluted (in dollars per share) $ (0.22) $ (0.54)
Weighted-average shares outstanding, basic (in shares) 418,064 233,661
Weighted-average shares outstanding, diluted (in shares) 418,064 233,661